Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Spinner

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
American Journal of Obstetrics and Gynecology|December 23, 2015
Chorioamniotic membrane separation and preterm premature rupture of membranes complicating in utero myelomeningocele repairShelly Soni, Julie S Moldenhauer, Susan S Spinner, et al.
JCO Oncology Practice|June 20, 2020
Treatment Decision Drivers in Stage III Non-Small-Cell Lung Cancer: Outcomes of a Web-Based Survey of Oncologists in the United StatesIon Cotarla, Marnie L Boron, Shawna L Cullen, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 28, 2016
Health Technology Assessment for Molecular Diagnostics: Practices, Challenges, and Recommendations from the Medical Devices and Diagnostics Special Interest GroupSusan Garfield, Julie Polisena, Daryl S Spinner, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
Next Generation Sequencing Technology: Health Technology Assessment, Market Access Trends and Potential Impacts on The Future of Companion Diagnostic TestingE C Faulkner, D S Spinner, J F Ransom, et al.
Viral Immunology|May 10, 2013
Altered lymphocyte proliferation and innate immune function in scrapie 139A- and ME7-infected miceIn Soo Cho, Daryl S Spinner, Richard J Kascsak, et al.
Healthcare (Basel, Switzerland)|October 27, 2022
Effective and Efficient Delivery of Genome-Based Testing-What Conditions Are Necessary for Health System Readiness?Don Husereau, Lotte Steuten, Vivek Muthu, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 13, 2009
Induction of toll-like receptor 9 signaling as a method for ameliorating Alzheimer's disease-related pathologyHenrieta Scholtzova, Richard J Kascsak, Kristyn A Bates, et al.
Current Oncology (Toronto, Ont.)|June 27, 2023
Progress toward Health System Readiness for Genome-Based Testing in CanadaDon Husereau, Eva Villalba, Vivek Muthu, et al.
The European Journal of Neuroscience|July 5, 2006
Clearance and prevention of prion infection in cell culture by anti-PrP antibodiesJoanna Pankiewicz, Frances Prelli, Man-Sun Sy, et al.
Current Oncology (Toronto, Ont.)|June 25, 2026
Readiness to Consider and Adopt Genetic and Genomic Tests in Canada-An Update to the State of Readiness ReportDon Husereau, Filomena Servidio-Italiano, Monika Slovinec D'Angelo, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
American Journal of Obstetrics and Gynecology|December 23, 2015
Chorioamniotic membrane separation and preterm premature rupture of membranes complicating in utero myelomeningocele repairShelly Soni, Julie S Moldenhauer, Susan S Spinner, et al.
JCO Oncology Practice|June 20, 2020
Treatment Decision Drivers in Stage III Non-Small-Cell Lung Cancer: Outcomes of a Web-Based Survey of Oncologists in the United StatesIon Cotarla, Marnie L Boron, Shawna L Cullen, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 28, 2016
Health Technology Assessment for Molecular Diagnostics: Practices, Challenges, and Recommendations from the Medical Devices and Diagnostics Special Interest GroupSusan Garfield, Julie Polisena, Daryl S Spinner, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
Next Generation Sequencing Technology: Health Technology Assessment, Market Access Trends and Potential Impacts on The Future of Companion Diagnostic TestingE C Faulkner, D S Spinner, J F Ransom, et al.
Viral Immunology|May 10, 2013
Altered lymphocyte proliferation and innate immune function in scrapie 139A- and ME7-infected miceIn Soo Cho, Daryl S Spinner, Richard J Kascsak, et al.
Healthcare (Basel, Switzerland)|October 27, 2022
Effective and Efficient Delivery of Genome-Based Testing-What Conditions Are Necessary for Health System Readiness?Don Husereau, Lotte Steuten, Vivek Muthu, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 13, 2009
Induction of toll-like receptor 9 signaling as a method for ameliorating Alzheimer's disease-related pathologyHenrieta Scholtzova, Richard J Kascsak, Kristyn A Bates, et al.
Current Oncology (Toronto, Ont.)|June 27, 2023
Progress toward Health System Readiness for Genome-Based Testing in CanadaDon Husereau, Eva Villalba, Vivek Muthu, et al.
The European Journal of Neuroscience|July 5, 2006
Clearance and prevention of prion infection in cell culture by anti-PrP antibodiesJoanna Pankiewicz, Frances Prelli, Man-Sun Sy, et al.
Current Oncology (Toronto, Ont.)|June 25, 2026
Readiness to Consider and Adopt Genetic and Genomic Tests in Canada-An Update to the State of Readiness ReportDon Husereau, Filomena Servidio-Italiano, Monika Slovinec D'Angelo, et al.
Pageof 5